Skip to main content

Clinical Update on the COVID-19 Pandemic

  • Chapter
  • First Online:
Headache Disorders in Pandemic Conditions

Part of the book series: Headache ((HEAD))

  • 157 Accesses

Abstract

Coronaviruses belong to Coronaviridae family and Orthocoronavirinae subfamily. Coronaviruses (27–32 kb) are enveloped, positive polarity, spherical RNA viruses with a single-stranded RNA genome. Six strains of coronaviruses were known to cause respiratory diseases in humans. Each human coronaviruses can lead to severe respiratory disease. Although it affects all age groups, it can lead to more serious disease in the elderly and people with multiple comorbidities. A new coronavirus, severe acute respiratory syndrome coronavirus-2, was identified and named in patients presenting with severe pneumonia in late 2019 in Wuhan, China. Later, it was announced by the World Health Organization (WHO) that this situation is a pandemic. Many people in the world have been affected, and millions of people have died by this disease.

The course of COVID-19 can be observed in a wide range, from asymptomatic infection to life-threatening severe disease. Although COVID-19 presents mostly with respiratory symptoms in patients, it has been reported that it can affect most of the organs and systems. An increasing number of neurological symptoms and manifestations have been reported in the present literature. Headache, dizziness, myalgia, loss of smell and taste, altered mental status, confusion, and delirium are the common and essential neurological symptoms of this disease. In this chapter, the characteristics of coronaviruses, the clinical features of COVID-19, and neurological manifestations of great concern such as stroke, cerebral venous thrombosis, seizures, meningoencephalitis, Guillain-Barre syndrome, and acute disseminated encephalomyelitis are discussed in detail.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Mohamadian M, Chiti H, Shoghli A, et al. COVID-19: virology, biology and novel laboratory diagnosis. J Gene Med. 2021;23:1–11.

    Article  Google Scholar 

  2. Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966;1:76–7.

    Article  CAS  PubMed  Google Scholar 

  3. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med. 1966;121:190–3.

    Article  CAS  PubMed  Google Scholar 

  4. Arabacı Ç, Aydın Tutak G, Eroğlu Kesim B, et al. The characteristics of SARS-CoV-2 virus and microbiological diagnosis. Eur Arch Med Res. 2020;36:10–20.

    Article  Google Scholar 

  5. Ogimi C, Kim YJ, Martin ET, et al. What’s new with the old coronaviruses? J Pediatr Infect Dis Soc. 2020;9:210–7.

    Article  CAS  Google Scholar 

  6. Guarner J. Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. Am J Clin Pathol. 2020;153:420–1.

    Article  CAS  PubMed  Google Scholar 

  7. Zhang AR, Shi WQ, Liu K, et al. Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012–2020. Infect Dis Poverty. 2021;10:1–13.

    CAS  Google Scholar 

  8. Cui J. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–92.

    Article  CAS  PubMed  Google Scholar 

  9. Jiang F, Deng L, Zhang L, et al. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med. 2020;35:1545–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Machhi J, Herskovitz J, Senan AM, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15:359–86.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. 2020;54:159–63.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Malik YA. Properties of coronavirus and SARS-CoV-2. Malays J Pathol. 2020;42:3–11.

    CAS  PubMed  Google Scholar 

  13. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In: Maier HJ, Brickerton E, Britton P, editors. Coronaviruses methods and protocols, vol. 1. Humana Press; 2015. p. 1–23.

    Google Scholar 

  14. Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol. 2020;85:104502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hasöksüz M, Kiliç S, Saraç F. Coronaviruses and sars-cov-2. Turk J Med Sci. 2020;50:549–56.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Setti L, Passarini F, De Gennaro G, et al. Airborne transmission route of covid-19: why 2 meters/6 feet of inter-personal distance could not be enough. Int J Environ Res Public Health. 2020;17:1–22.

    Article  Google Scholar 

  17. Kadam SB, Sukhramani GS, Bishnoi P, et al. SARS-CoV-2, the pandemic coronavirus: molecular and structural insights. J Basic Microbiol. 2021;61:180–202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Niazkar M, Niazkar HR. COVID-19 outbreak: application of multi-gene genetic programming to country-based prediction models. Electron J Gen Med. 2020;17(5):247.

    Article  Google Scholar 

  19. Pradhan M, Shah K, Alexander A, et al. COVID-19: clinical presentation and detection methods. J Immunoass Immunochem. 2022;43:1–21.

    Article  Google Scholar 

  20. Chen Z, Boon SS, Wang MH, et al. Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses. J Virol Methods. 2021;289:114032.

    Article  CAS  PubMed  Google Scholar 

  21. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–30.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kayaaslan B, Eser F, Kalem AK, et al. Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol. 2021;93:6566–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bobker SM, Robbins MS. COVID-19 and headache: a primer for trainees. Headache. 2020;60:1806–11.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:1.

    Article  Google Scholar 

  26. Divani A, Andalib S, Di Napoli M, Lattanzi S, Hussain M, Biller J, et al. Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights. J Stroke Cerebrovasc Dis. 2020;29(8):104941.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza RF, Santos NO, Dos Santos Freitas A, Ribeiro da Silveira P, Tiwari S, Alzahrani KJ, Góes-Neto A, Azevedo V, Ghosh P, Barh D. Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Libbey JE, Fujinami RS. Neurotropic viral infections leading to epilepsy: focus on Theiler’s murine encephalomyelitis virus. Future Virol. 2011;6:1339–50.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Roy D, Ghosh R, Dubey S, et al. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2021;48:9–24.

    Article  PubMed  Google Scholar 

  32. Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296:E119–20.

    Article  PubMed  Google Scholar 

  33. Burks JS, Devald BL, Jankovsky LD, Gerdes JC. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science. 1980;209:933–4.

    Article  CAS  PubMed  Google Scholar 

  34. Mahalakshmi AM, Ray B, Tuladhar S, et al. Does COVID-19 contribute to development of neurological disease? Immun Inflamm Dis. 2021;9:48–58.

    Article  CAS  PubMed  Google Scholar 

  35. Parsons T, Banks S, Bae C, et al. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020;267:2799–802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin Infect Dis. 2020;71:889–90.

    Article  CAS  PubMed  Google Scholar 

  37. Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, et al. Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. 2020;20:1015–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Dra A, Chancy M, Mendoza A, et al. Priapismo isquémico refractario . Complicación tromboembólica secundaria a la infección severa por SARSCoV-2 ? Reporte de caso y revisión de la literatura. 2021;2021:12890.

    Google Scholar 

  39. Caress JB, Castoro RJ, Simmons Z, et al. COVID-19–associated Guillain-Barré syndrome: the early pandemic experience. Muscle Nerve. 2020;62:485–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Assini A, Benedetti L, Di Maio S, et al. Correction to: new clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. 2020;41:7. (1657-1658)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ayhan, M., Coşkun, B., Güner, R. (2023). Clinical Update on the COVID-19 Pandemic. In: Özge, A., Uludüz, D., Bolay, H., Karadaş, Ö. (eds) Headache Disorders in Pandemic Conditions . Headache. Springer, Cham. https://doi.org/10.1007/978-3-031-26309-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-26309-5_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-26308-8

  • Online ISBN: 978-3-031-26309-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics